img

Global Inhaled NO Vasodilator Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Inhaled NO Vasodilator Market Insights, Forecast to 2034

Inhaled NO Vasodilator is a medical treatment used to dilate blood vessels and improve blood flow in conditions like pulmonary hypertension. Inhaled nitric oxide is delivered via a specialized device that allows patients to breathe in the gas, leading to relaxation of blood vessel walls and enhanced oxygen exchange in the lungs.
Global Inhaled NO Vasodilator market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Inhaled NO Vasodilator industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2024, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers
This report presents an overview of global Inhaled NO Vasodilator market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Inhaled NO Vasodilator market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Mallinckrodt
Praxair (Linde plc)
Air Liquide
BOC Healthcare (Linde Group)
Segment by Type
800 ppm
100 ppm
Others

Segment by Application


PPHN
ARDS
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Inhaled NO Vasodilator plant distribution, commercial date of Inhaled NO Vasodilator, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Inhaled NO Vasodilator introduction, etc. Inhaled NO Vasodilator Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Inhaled NO Vasodilator
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Inhaled NO Vasodilator Product Introduction
1.2 Market by Type
1.2.1 Global Inhaled NO Vasodilator Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 800 ppm
1.2.3 100 ppm
1.2.4 Others
1.3 Market by Application
1.3.1 Global Inhaled NO Vasodilator Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 PPHN
1.3.3 ARDS
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Inhaled NO Vasodilator Sales Estimates and Forecasts 2018-2029
2.2 Global Inhaled NO Vasodilator Revenue by Region
2.2.1 Global Inhaled NO Vasodilator Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Inhaled NO Vasodilator Revenue by Region (2018-2024)
2.2.3 Global Inhaled NO Vasodilator Revenue by Region (2024-2029)
2.2.4 Global Inhaled NO Vasodilator Revenue Market Share by Region (2018-2029)
2.3 Global Inhaled NO Vasodilator Sales Estimates and Forecasts 2018-2029
2.4 Global Inhaled NO Vasodilator Sales by Region
2.4.1 Global Inhaled NO Vasodilator Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Inhaled NO Vasodilator Sales by Region (2018-2024)
2.4.3 Global Inhaled NO Vasodilator Sales by Region (2024-2029)
2.4.4 Global Inhaled NO Vasodilator Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Inhaled NO Vasodilator Sales by Manufacturers
3.1.1 Global Inhaled NO Vasodilator Sales by Manufacturers (2018-2024)
3.1.2 Global Inhaled NO Vasodilator Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Inhaled NO Vasodilator in 2022
3.2 Global Inhaled NO Vasodilator Revenue by Manufacturers
3.2.1 Global Inhaled NO Vasodilator Revenue by Manufacturers (2018-2024)
3.2.2 Global Inhaled NO Vasodilator Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Inhaled NO Vasodilator Revenue in 2022
3.3 Global Key Players of Inhaled NO Vasodilator, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Inhaled NO Vasodilator Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Inhaled NO Vasodilator Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Inhaled NO Vasodilator, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Inhaled NO Vasodilator, Product Offered and Application
3.8 Global Key Manufacturers of Inhaled NO Vasodilator, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Inhaled NO Vasodilator Sales by Type
4.1.1 Global Inhaled NO Vasodilator Historical Sales by Type (2018-2024)
4.1.2 Global Inhaled NO Vasodilator Forecasted Sales by Type (2024-2029)
4.1.3 Global Inhaled NO Vasodilator Sales Market Share by Type (2018-2029)
4.2 Global Inhaled NO Vasodilator Revenue by Type
4.2.1 Global Inhaled NO Vasodilator Historical Revenue by Type (2018-2024)
4.2.2 Global Inhaled NO Vasodilator Forecasted Revenue by Type (2024-2029)
4.2.3 Global Inhaled NO Vasodilator Revenue Market Share by Type (2018-2029)
4.3 Global Inhaled NO Vasodilator Price by Type
4.3.1 Global Inhaled NO Vasodilator Price by Type (2018-2024)
4.3.2 Global Inhaled NO Vasodilator Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Inhaled NO Vasodilator Sales by Application
5.1.1 Global Inhaled NO Vasodilator Historical Sales by Application (2018-2024)
5.1.2 Global Inhaled NO Vasodilator Forecasted Sales by Application (2024-2029)
5.1.3 Global Inhaled NO Vasodilator Sales Market Share by Application (2018-2029)
5.2 Global Inhaled NO Vasodilator Revenue by Application
5.2.1 Global Inhaled NO Vasodilator Historical Revenue by Application (2018-2024)
5.2.2 Global Inhaled NO Vasodilator Forecasted Revenue by Application (2024-2029)
5.2.3 Global Inhaled NO Vasodilator Revenue Market Share by Application (2018-2029)
5.3 Global Inhaled NO Vasodilator Price by Application
5.3.1 Global Inhaled NO Vasodilator Price by Application (2018-2024)
5.3.2 Global Inhaled NO Vasodilator Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Inhaled NO Vasodilator Market Size by Type
6.1.1 US & Canada Inhaled NO Vasodilator Sales by Type (2018-2029)
6.1.2 US & Canada Inhaled NO Vasodilator Revenue by Type (2018-2029)
6.2 US & Canada Inhaled NO Vasodilator Market Size by Application
6.2.1 US & Canada Inhaled NO Vasodilator Sales by Application (2018-2029)
6.2.2 US & Canada Inhaled NO Vasodilator Revenue by Application (2018-2029)
6.3 US & Canada Inhaled NO Vasodilator Market Size by Country
6.3.1 US & Canada Inhaled NO Vasodilator Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Inhaled NO Vasodilator Sales by Country (2018-2029)
6.3.3 US & Canada Inhaled NO Vasodilator Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Inhaled NO Vasodilator Market Size by Type
7.1.1 Europe Inhaled NO Vasodilator Sales by Type (2018-2029)
7.1.2 Europe Inhaled NO Vasodilator Revenue by Type (2018-2029)
7.2 Europe Inhaled NO Vasodilator Market Size by Application
7.2.1 Europe Inhaled NO Vasodilator Sales by Application (2018-2029)
7.2.2 Europe Inhaled NO Vasodilator Revenue by Application (2018-2029)
7.3 Europe Inhaled NO Vasodilator Market Size by Country
7.3.1 Europe Inhaled NO Vasodilator Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Inhaled NO Vasodilator Sales by Country (2018-2029)
7.3.3 Europe Inhaled NO Vasodilator Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Inhaled NO Vasodilator Market Size
8.1.1 China Inhaled NO Vasodilator Sales (2018-2029)
8.1.2 China Inhaled NO Vasodilator Revenue (2018-2029)
8.2 China Inhaled NO Vasodilator Market Size by Application
8.2.1 China Inhaled NO Vasodilator Sales by Application (2018-2029)
8.2.2 China Inhaled NO Vasodilator Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Inhaled NO Vasodilator Market Size by Type
9.1.1 Asia Inhaled NO Vasodilator Sales by Type (2018-2029)
9.1.2 Asia Inhaled NO Vasodilator Revenue by Type (2018-2029)
9.2 Asia Inhaled NO Vasodilator Market Size by Application
9.2.1 Asia Inhaled NO Vasodilator Sales by Application (2018-2029)
9.2.2 Asia Inhaled NO Vasodilator Revenue by Application (2018-2029)
9.3 Asia Inhaled NO Vasodilator Sales by Region
9.3.1 Asia Inhaled NO Vasodilator Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Inhaled NO Vasodilator Revenue by Region (2018-2029)
9.3.3 Asia Inhaled NO Vasodilator Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Inhaled NO Vasodilator Market Size by Type
10.1.1 Middle East, Africa and Latin America Inhaled NO Vasodilator Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Inhaled NO Vasodilator Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Inhaled NO Vasodilator Market Size by Application
10.2.1 Middle East, Africa and Latin America Inhaled NO Vasodilator Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Inhaled NO Vasodilator Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Inhaled NO Vasodilator Sales by Country
10.3.1 Middle East, Africa and Latin America Inhaled NO Vasodilator Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Inhaled NO Vasodilator Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Inhaled NO Vasodilator Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Mallinckrodt
11.1.1 Mallinckrodt Company Information
11.1.2 Mallinckrodt Overview
11.1.3 Mallinckrodt Inhaled NO Vasodilator Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Mallinckrodt Inhaled NO Vasodilator Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Mallinckrodt Recent Developments
11.2 Praxair (Linde plc)
11.2.1 Praxair (Linde plc) Company Information
11.2.2 Praxair (Linde plc) Overview
11.2.3 Praxair (Linde plc) Inhaled NO Vasodilator Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Praxair (Linde plc) Inhaled NO Vasodilator Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Praxair (Linde plc) Recent Developments
11.3 Air Liquide
11.3.1 Air Liquide Company Information
11.3.2 Air Liquide Overview
11.3.3 Air Liquide Inhaled NO Vasodilator Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Air Liquide Inhaled NO Vasodilator Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Air Liquide Recent Developments
11.4 BOC Healthcare (Linde Group)
11.4.1 BOC Healthcare (Linde Group) Company Information
11.4.2 BOC Healthcare (Linde Group) Overview
11.4.3 BOC Healthcare (Linde Group) Inhaled NO Vasodilator Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 BOC Healthcare (Linde Group) Inhaled NO Vasodilator Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BOC Healthcare (Linde Group) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Inhaled NO Vasodilator Industry Chain Analysis
12.2 Inhaled NO Vasodilator Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Inhaled NO Vasodilator Production Mode & Process
12.4 Inhaled NO Vasodilator Sales and Marketing
12.4.1 Inhaled NO Vasodilator Sales Channels
12.4.2 Inhaled NO Vasodilator Distributors
12.5 Inhaled NO Vasodilator Customers
13 Market Dynamics
13.1 Inhaled NO Vasodilator Industry Trends
13.2 Inhaled NO Vasodilator Market Drivers
13.3 Inhaled NO Vasodilator Market Challenges
13.4 Inhaled NO Vasodilator Market Restraints
14 Key Findings in The Global Inhaled NO Vasodilator Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Inhaled NO Vasodilator Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 800 ppm
Table 3. Major Manufacturers of 100 ppm
Table 4. Major Manufacturers of Others
Table 5. Global Inhaled NO Vasodilator Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Inhaled NO Vasodilator Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Inhaled NO Vasodilator Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Inhaled NO Vasodilator Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Inhaled NO Vasodilator Revenue Market Share by Region (2018-2024)
Table 10. Global Inhaled NO Vasodilator Revenue Market Share by Region (2024-2029)
Table 11. Global Inhaled NO Vasodilator Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Inhaled NO Vasodilator Sales by Region (2018-2024) & (K Units)
Table 13. Global Inhaled NO Vasodilator Sales by Region (2024-2029) & (K Units)
Table 14. Global Inhaled NO Vasodilator Sales Market Share by Region (2018-2024)
Table 15. Global Inhaled NO Vasodilator Sales Market Share by Region (2024-2029)
Table 16. Global Inhaled NO Vasodilator Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Inhaled NO Vasodilator Sales Share by Manufacturers (2018-2024)
Table 18. Global Inhaled NO Vasodilator Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Inhaled NO Vasodilator Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Inhaled NO Vasodilator, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Inhaled NO Vasodilator Price by Manufacturers 2018-2024 (US$/Unit)
Table 22. Global Inhaled NO Vasodilator Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Inhaled NO Vasodilator by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled NO Vasodilator as of 2022)
Table 24. Global Key Manufacturers of Inhaled NO Vasodilator, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Inhaled NO Vasodilator, Product Offered and Application
Table 26. Global Key Manufacturers of Inhaled NO Vasodilator, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Inhaled NO Vasodilator Sales by Type (2018-2024) & (K Units)
Table 29. Global Inhaled NO Vasodilator Sales by Type (2024-2029) & (K Units)
Table 30. Global Inhaled NO Vasodilator Sales Share by Type (2018-2024)
Table 31. Global Inhaled NO Vasodilator Sales Share by Type (2024-2029)
Table 32. Global Inhaled NO Vasodilator Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Inhaled NO Vasodilator Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Inhaled NO Vasodilator Revenue Share by Type (2018-2024)
Table 35. Global Inhaled NO Vasodilator Revenue Share by Type (2024-2029)
Table 36. Inhaled NO Vasodilator Price by Type (2018-2024) & (US$/Unit)
Table 37. Global Inhaled NO Vasodilator Price Forecast by Type (2024-2029) & (US$/Unit)
Table 38. Global Inhaled NO Vasodilator Sales by Application (2018-2024) & (K Units)
Table 39. Global Inhaled NO Vasodilator Sales by Application (2024-2029) & (K Units)
Table 40. Global Inhaled NO Vasodilator Sales Share by Application (2018-2024)
Table 41. Global Inhaled NO Vasodilator Sales Share by Application (2024-2029)
Table 42. Global Inhaled NO Vasodilator Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Inhaled NO Vasodilator Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Inhaled NO Vasodilator Revenue Share by Application (2018-2024)
Table 45. Global Inhaled NO Vasodilator Revenue Share by Application (2024-2029)
Table 46. Inhaled NO Vasodilator Price by Application (2018-2024) & (US$/Unit)
Table 47. Global Inhaled NO Vasodilator Price Forecast by Application (2024-2029) & (US$/Unit)
Table 48. US & Canada Inhaled NO Vasodilator Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Inhaled NO Vasodilator Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Inhaled NO Vasodilator Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Inhaled NO Vasodilator Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Inhaled NO Vasodilator Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Inhaled NO Vasodilator Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Inhaled NO Vasodilator Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Inhaled NO Vasodilator Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Inhaled NO Vasodilator Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Inhaled NO Vasodilator Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Inhaled NO Vasodilator Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Inhaled NO Vasodilator Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Inhaled NO Vasodilator Sales by Country (2024-2029) & (K Units)
Table 61. Europe Inhaled NO Vasodilator Sales by Type (2018-2024) & (K Units)
Table 62. Europe Inhaled NO Vasodilator Sales by Type (2024-2029) & (K Units)
Table 63. Europe Inhaled NO Vasodilator Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Inhaled NO Vasodilator Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Inhaled NO Vasodilator Sales by Application (2018-2024) & (K Units)
Table 66. Europe Inhaled NO Vasodilator Sales by Application (2024-2029) & (K Units)
Table 67. Europe Inhaled NO Vasodilator Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Inhaled NO Vasodilator Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Inhaled NO Vasodilator Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Inhaled NO Vasodilator Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Inhaled NO Vasodilator Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Inhaled NO Vasodilator Sales by Country (2018-2024) & (K Units)
Table 73. Europe Inhaled NO Vasodilator Sales by Country (2024-2029) & (K Units)
Table 74. China Inhaled NO Vasodilator Sales by Type (2018-2024) & (K Units)
Table 75. China Inhaled NO Vasodilator Sales by Type (2024-2029) & (K Units)
Table 76. China Inhaled NO Vasodilator Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Inhaled NO Vasodilator Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Inhaled NO Vasodilator Sales by Application (2018-2024) & (K Units)
Table 79. China Inhaled NO Vasodilator Sales by Application (2024-2029) & (K Units)
Table 80. China Inhaled NO Vasodilator Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Inhaled NO Vasodilator Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Inhaled NO Vasodilator Sales by Type (2018-2024) & (K Units)
Table 83. Asia Inhaled NO Vasodilator Sales by Type (2024-2029) & (K Units)
Table 84. Asia Inhaled NO Vasodilator Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Inhaled NO Vasodilator Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Inhaled NO Vasodilator Sales by Application (2018-2024) & (K Units)
Table 87. Asia Inhaled NO Vasodilator Sales by Application (2024-2029) & (K Units)
Table 88. Asia Inhaled NO Vasodilator Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Inhaled NO Vasodilator Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Inhaled NO Vasodilator Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Inhaled NO Vasodilator Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Inhaled NO Vasodilator Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Inhaled NO Vasodilator Sales by Region (2018-2024) & (K Units)
Table 94. Asia Inhaled NO Vasodilator Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Inhaled NO Vasodilator Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Inhaled NO Vasodilator Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Inhaled NO Vasodilator Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Inhaled NO Vasodilator Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Inhaled NO Vasodilator Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Inhaled NO Vasodilator Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Inhaled NO Vasodilator Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Inhaled NO Vasodilator Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Inhaled NO Vasodilator Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Inhaled NO Vasodilator Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Inhaled NO Vasodilator Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Inhaled NO Vasodilator Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Inhaled NO Vasodilator Sales by Country (2024-2029) & (K Units)
Table 108. Mallinckrodt Company Information
Table 109. Mallinckrodt Description and Major Businesses
Table 110. Mallinckrodt Inhaled NO Vasodilator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Mallinckrodt Inhaled NO Vasodilator Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Mallinckrodt Recent Developments
Table 113. Praxair (Linde plc) Company Information
Table 114. Praxair (Linde plc) Description and Major Businesses
Table 115. Praxair (Linde plc) Inhaled NO Vasodilator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Praxair (Linde plc) Inhaled NO Vasodilator Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Praxair (Linde plc) Recent Developments
Table 118. Air Liquide Company Information
Table 119. Air Liquide Description and Major Businesses
Table 120. Air Liquide Inhaled NO Vasodilator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Air Liquide Inhaled NO Vasodilator Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Air Liquide Recent Developments
Table 123. BOC Healthcare (Linde Group) Company Information
Table 124. BOC Healthcare (Linde Group) Description and Major Businesses
Table 125. BOC Healthcare (Linde Group) Inhaled NO Vasodilator Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. BOC Healthcare (Linde Group) Inhaled NO Vasodilator Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. BOC Healthcare (Linde Group) Recent Developments
Table 128. Key Raw Materials Lists
Table 129. Raw Materials Key Suppliers Lists
Table 130. Inhaled NO Vasodilator Distributors List
Table 131. Inhaled NO Vasodilator Customers List
Table 132. Inhaled NO Vasodilator Market Trends
Table 133. Inhaled NO Vasodilator Market Drivers
Table 134. Inhaled NO Vasodilator Market Challenges
Table 135. Inhaled NO Vasodilator Market Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Inhaled NO Vasodilator Product Picture
Figure 2. Global Inhaled NO Vasodilator Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Inhaled NO Vasodilator Market Share by Type in 2022 & 2029
Figure 4. 800 ppm Product Picture
Figure 5. 100 ppm Product Picture
Figure 6. Others Product Picture
Figure 7. Global Inhaled NO Vasodilator Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Inhaled NO Vasodilator Market Share by Application in 2022 & 2029
Figure 9. PPHN
Figure 10. ARDS
Figure 11. Others
Figure 12. Inhaled NO Vasodilator Report Years Considered
Figure 13. Global Inhaled NO Vasodilator Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Inhaled NO Vasodilator Revenue 2018-2029 (US$ Million)
Figure 15. Global Inhaled NO Vasodilator Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Inhaled NO Vasodilator Revenue Market Share by Region (2018-2029)
Figure 17. Global Inhaled NO Vasodilator Sales 2018-2029 ((K Units)
Figure 18. Global Inhaled NO Vasodilator Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Inhaled NO Vasodilator Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Inhaled NO Vasodilator Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Inhaled NO Vasodilator Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Inhaled NO Vasodilator Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Inhaled NO Vasodilator Sales YoY (2018-2029) & (K Units)
Figure 24. China Inhaled NO Vasodilator Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Inhaled NO Vasodilator Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Inhaled NO Vasodilator Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Inhaled NO Vasodilator Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Inhaled NO Vasodilator Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Inhaled NO Vasodilator Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Inhaled NO Vasodilator in the World: Market Share by Inhaled NO Vasodilator Revenue in 2022
Figure 31. Global Inhaled NO Vasodilator Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Inhaled NO Vasodilator Sales Market Share by Type (2018-2029)
Figure 33. Global Inhaled NO Vasodilator Revenue Market Share by Type (2018-2029)
Figure 34. Global Inhaled NO Vasodilator Sales Market Share by Application (2018-2029)
Figure 35. Global Inhaled NO Vasodilator Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Inhaled NO Vasodilator Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Inhaled NO Vasodilator Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Inhaled NO Vasodilator Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Inhaled NO Vasodilator Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Inhaled NO Vasodilator Revenue Share by Country (2018-2029)
Figure 41. US & Canada Inhaled NO Vasodilator Sales Share by Country (2018-2029)
Figure 42. U.S. Inhaled NO Vasodilator Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Inhaled NO Vasodilator Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Inhaled NO Vasodilator Sales Market Share by Type (2018-2029)
Figure 45. Europe Inhaled NO Vasodilator Revenue Market Share by Type (2018-2029)
Figure 46. Europe Inhaled NO Vasodilator Sales Market Share by Application (2018-2029)
Figure 47. Europe Inhaled NO Vasodilator Revenue Market Share by Application (2018-2029)
Figure 48. Europe Inhaled NO Vasodilator Revenue Share by Country (2018-2029)
Figure 49. Europe Inhaled NO Vasodilator Sales Share by Country (2018-2029)
Figure 50. Germany Inhaled NO Vasodilator Revenue (2018-2029) & (US$ Million)
Figure 51. France Inhaled NO Vasodilator Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Inhaled NO Vasodilator Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Inhaled NO Vasodilator Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Inhaled NO Vasodilator Revenue (2018-2029) & (US$ Million)
Figure 55. China Inhaled NO Vasodilator Sales Market Share by Type (2018-2029)
Figure 56. China Inhaled NO Vasodilator Revenue Market Share by Type (2018-2029)
Figure 57. China Inhaled NO Vasodilator Sales Market Share by Application (2018-2029)
Figure 58. China Inhaled NO Vasodilator Revenue Market Share by Application (2018-2029)
Figure 59. Asia Inhaled NO Vasodilator Sales Market Share by Type (2018-2029)
Figure 60. Asia Inhaled NO Vasodilator Revenue Market Share by Type (2018-2029)
Figure 61. Asia Inhaled NO Vasodilator Sales Market Share by Application (2018-2029)
Figure 62. Asia Inhaled NO Vasodilator Revenue Market Share by Application (2018-2029)
Figure 63. Asia Inhaled NO Vasodilator Revenue Share by Region (2018-2029)
Figure 64. Asia Inhaled NO Vasodilator Sales Share by Region (2018-2029)
Figure 65. Japan Inhaled NO Vasodilator Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Inhaled NO Vasodilator Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Inhaled NO Vasodilator Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Inhaled NO Vasodilator Revenue (2018-2029) & (US$ Million)
Figure 69. India Inhaled NO Vasodilator Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Inhaled NO Vasodilator Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Inhaled NO Vasodilator Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Inhaled NO Vasodilator Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Inhaled NO Vasodilator Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Inhaled NO Vasodilator Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Inhaled NO Vasodilator Sales Share by Country (2018-2029)
Figure 76. Brazil Inhaled NO Vasodilator Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Inhaled NO Vasodilator Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Inhaled NO Vasodilator Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Inhaled NO Vasodilator Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Inhaled NO Vasodilator Revenue (2018-2029) & (US$ Million)
Figure 81. Inhaled NO Vasodilator Value Chain
Figure 82. Inhaled NO Vasodilator Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries